Omedica, UAB - financials and debts

Company age: 33 y. 7 mo.

Update

Omedica - Company finances

EUR
2018
From: 2018-01-01
To: 2018-12-31
2019
From: 2019-01-01
To: 2019-12-31
2020
From: 2020-01-01
To: 2020-12-31
2021
From: 2021-01-01
To: 2021-12-31
2022
From: 2022-01-01
To: 2022-12-31
2023
From: 2023-01-01
To: 2023-12-31
2024
From: 2024-01-01
To: 2024-12-31
2025
From: 2025-01-01
To: 2025-12-31
Financial data
Sales revenue 312,125 301,854 287,587 56,939 480,030 796,236 1,057,167 1,290,232
Profit before tax 297 755 54 -8,410 58,400 100,687 144,885 137,792
Net profit 252 642 46 -8,410 58,400 100,687 144,885 115,746
Equity 70,256 70,898 70,944 70,944 120,934 200,445 274,742 199,900
Liabilities 79,375 68,846 66,964 135,150 211,890 118,351 133,165 210,086
Non-current assets 24,841 23,921 23,883 108,084 232,718 152,258 142,238 122,976
Current assets 124,790 115,823 114,025 89,600 100,106 166,538 265,669 287,010
Total assets 149,631 139,744 137,908 197,684 332,824 318,796 407,907 409,986
Taxes paid
STI taxes - - - - - 82,042 142,701 190,634
Social insurance contributions - - - - - 91,675 127,003 158,724
Financial indicators
Revenue change y/y +13.4% -3.3% -4.7% -80.2% +743.1% +65.9% +32.8% +22.0%
ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. 0.2% 0.5% 0.0% -4.3% 17.5% 31.6% 35.5% 28.2%
ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. 0.4% 0.9% 0.1% -11.9% 48.3% 50.2% 52.7% 57.9%
Profit margin Net profit margin. Shows the overall profitability of the company. 0.1% 0.2% 0.0% -14.8% 12.2% 12.6% 13.7% 9.0%
EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. 0.1% 0.3% 0.0% -14.8% 12.2% 12.6% 13.7% 10.7%
Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. 1.1 1.0 0.9 1.9 1.8 0.6 0.5 1.1
Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. 62,425 75,464 71,897 20,096 44,654 47,774 49,945 56,097

Purchase full financial statements

Profit/Loss, Balance Sheet, Cash Flow, Equity

9.99 € + PVM Buy

Sales revenue

See Scoris data in Google Search

Mark Scoris as a favorite source. One click, no registration.

Omedica - Social security debts

From To Debt, €
2026-08-26 2026-08-30 174.86
2026-08-23 2026-08-23 174.86
2026-08-19 2026-08-19 174.86
2022-04-28 2022-05-15 3.60
2022-03-16 2022-03-17 2947.25

Omedica - VMI tax arrears

From To Overdue, €
2025-06-17 2025-06-17 24338.69
2025-02-20 2025-02-25 91.2
2025-02-12 2025-02-17 2.53
2025-02-02 2025-02-11 922.86
2025-01-31 2025-02-01 921.94
2025-01-29 2025-01-30 925.18
2025-01-28 2025-01-28 1386.18
2025-01-22 2025-01-27 1383.86

VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.

Analysis of the company's financial position

This description was generated by artificial intelligence. Report if inaccurate.
Omedica, UAB (code 174943760) is a private limited liability company engaged in general medical practice activities. In 2025, it generated revenue of €1.29M, up 22.1% year on year and 62.0% over two years, extending the growth trend seen from €796.2K in 2023 to €1.06M in 2024 and then to the latest level. Net profit in 2025 was €115.7K, below the €144.9K achieved in 2024 but above the €100.7K recorded in 2023. The 2025 profit margin was 9.0%, compared with 13.7% in 2024 and 12.6% in 2023. At year-end 2025, total assets stood at €410.0K, equity at €199.9K and liabilities at €210.1K. Key ratios remained solid, with ROE at 57.9%, ROA at 28.2%, debt-to-equity at 1.05 and asset turnover at 3.15x. Revenue per employee was €56.1K and profit per employee was €5.0K, indicating a relatively productive operating base.